Xcout Intel
FIREBRICK PHARMA LIMITED
Firebrick Pharma Limited, an enterprise established in 2012 and headquartered in Melbourne, Australia, is dedicated to the research, development, and market launch of Nasodine, a nasal spray treatment for the common cold, exclusively for the Australian market.
Subscribe to see FIREBRICK PHARMA LIMITED’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
FIREBRICK PHARMA LIMITED at a glance
FIREBRICK PHARMA LIMITED is a pharmaceuticals, biotechnology & life sciences company headquartered in Melbourne, Australia. It is publicly listed (FRE) with a market capitalisation of $4.8M. Xcout tracks 8 named people at FIREBRICK PHARMA LIMITED, including Simon Tucker (Chief Scientific Officer, BSc (Hons), PhD).
FIREBRICK PHARMA LIMITED leadership
- Simon TuckerChief Scientific Officer, BSc (Hons), PhD
- Stephen GoodallFounder, Director & COO, BAppSc, MAppSc, MBA, PhD
- Peter MolloyFounder & Executive Chairman, BSc, MBA, PhD
- Monique BaldwinHead of Regulatory Affairs, BSc (Hons), MBioethics, PhD
- Nilesh WadhwaBusiness Development Director
- Kam WatsonMarketing Administration Manager
2 more named people on record for FIREBRICK PHARMA LIMITED, with roles, board committees and tenure — see the full roster →
Get FIREBRICK PHARMA LIMITED's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on FIREBRICK PHARMA LIMITED in Xcout Intel
- 8 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access